Penumbra Inc (PEN) - Total Liabilities
Based on the latest financial reports, Penumbra Inc (PEN) has total liabilities worth $385.67 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Penumbra Inc generate cash to assess how effectively this company generates cash.
Penumbra Inc - Total Liabilities Trend (2013–2024)
This chart illustrates how Penumbra Inc's total liabilities have evolved over time, based on quarterly financial data. Check Penumbra Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Penumbra Inc Competitors by Total Liabilities
The table below lists competitors of Penumbra Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Solstice Advanced Materials, Inc
NASDAQ:SOLS
|
USA | $4.30 Billion |
|
Fox Corp Class B
NASDAQ:FOX
|
USA | $10.35 Billion |
|
Sinopac Financial Holdings Co Ltd
TW:2890
|
Taiwan | NT$2.86 Trillion |
|
VERBUND AG
VI:VER
|
Austria | €7.33 Billion |
|
Synnex Corporation
NYSE:SNX
|
USA | $25.80 Billion |
|
McCormick & Company Incorporated
NYSE:MKC
|
USA | $7.43 Billion |
|
KT&G Corp
KO:033780
|
Korea | ₩5.61 Trillion |
|
COLOPLAST SP.ADR 1/10 DK1
F:CBH
|
Germany | €34.99 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Penumbra Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Penumbra Inc market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 1.89 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Penumbra Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Penumbra Inc (2013–2024)
The table below shows the annual total liabilities of Penumbra Inc from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $382.25 Million | +1.30% |
| 2023-12-31 | $377.36 Million | +1.43% |
| 2022-12-31 | $372.03 Million | +28.14% |
| 2021-12-31 | $290.32 Million | +56.77% |
| 2020-12-31 | $185.19 Million | +2.72% |
| 2019-12-31 | $180.29 Million | +94.71% |
| 2018-12-31 | $92.59 Million | +21.42% |
| 2017-12-31 | $76.26 Million | +82.84% |
| 2016-12-31 | $41.71 Million | +33.14% |
| 2015-12-31 | $31.33 Million | -76.58% |
| 2014-12-31 | $133.75 Million | +68.86% |
| 2013-12-31 | $79.21 Million | -- |
About Penumbra Inc
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also… Read more